Phase 2 Study of Amivantamab Plus Lazertinib in Previously Treated Patients With EGFR-Mutant Lung Cancers With Brain and Leptomeningeal Metastases

作者：Monica F. Chen, Jake June-Koo Lee, Noura J. Choudhury, Angela B. Hui, Mark Jeng, Jennifer Zheng, Rania G. Aly, Neil Sielski, Linda S. Ahn, Amanda Pupo, Monica Nesselbush, Isabel Jabara, Jessica Wilcox, Bianca Santomasso, Andrew Lin, Lauren Schaff, Jamie E. Chaft, Gregory J. Riely, Mark G. Kris, Andrea Arfè, Soo-Ryum Yang, Robert J. Young, Maximilian Diehn, Adrienne Boire, Helena A. Yu · 发表于：Journal of Thoracic Oncology · 年份：2025 · DOI：10.1016/j.jtho.2025.10.012 · 被引用次数：4 · 研究领域：Lung Cancer Treatments and Mutations、Brain Metastases and Treatment、Lung Cancer Research Studies